Victory Capital Management Inc. Purchases 6,462 Shares of Clorox Co (NYSE:CLX)

Victory Capital Management Inc. lifted its position in Clorox Co (NYSE:CLX) by 3.0% in the 3rd quarter, Holdings Channel reports. The fund owned 224,423 shares of the company’s stock after acquiring an additional 6,462 shares during the quarter. Victory Capital Management Inc.’s holdings in Clorox were worth $47,167,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in CLX. Costello Asset Management INC bought a new position in shares of Clorox in the 2nd quarter worth approximately $27,000. RPG Investment Advisory LLC increased its position in Clorox by 98.5% during the 2nd quarter. RPG Investment Advisory LLC now owns 129 shares of the company’s stock valued at $28,000 after buying an additional 64 shares in the last quarter. Hall Laurie J Trustee bought a new position in Clorox during the 3rd quarter valued at approximately $28,000. Rosenberg Matthew Hamilton bought a new position in Clorox during the 2nd quarter valued at approximately $29,000. Finally, Newfound Research LLC bought a new position in Clorox during the 3rd quarter valued at approximately $29,000. 75.81% of the stock is owned by hedge funds and other institutional investors.

A number of research analysts recently weighed in on CLX shares. DA Davidson raised their price objective on Clorox from $263.00 to $268.00 and gave the company a “buy” rating in a research report on Tuesday, November 3rd. Royal Bank of Canada raised their price objective on Clorox from $218.00 to $221.00 and gave the company a “sector perform” rating in a research report on Tuesday, November 3rd. Smith Barney Citigroup reduced their price objective on Clorox from $245.00 to $238.00 in a research report on Tuesday, November 3rd. Credit Suisse Group raised their price objective on Clorox from $185.00 to $200.00 and gave the company a “neutral” rating in a research report on Tuesday, August 4th. Finally, JPMorgan Chase & Co. downgraded Clorox from an “overweight” rating to a “neutral” rating and set a $235.00 target price on the stock. in a research note on Friday, October 16th. They noted that the move was a valuation call. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $215.23.

In other news, EVP Eric H. Reynolds sold 1,824 shares of the firm’s stock in a transaction on Tuesday, November 17th. The stock was sold at an average price of $207.41, for a total value of $378,315.84. Following the transaction, the executive vice president now directly owns 21,546 shares in the company, valued at approximately $4,468,855.86. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP William S. Bailey sold 15,114 shares of the firm’s stock in a transaction on Tuesday, November 3rd. The stock was sold at an average price of $212.47, for a total value of $3,211,271.58. Following the completion of the transaction, the senior vice president now owns 13,447 shares in the company, valued at $2,857,084.09. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 46,381 shares of company stock worth $9,893,347. Company insiders own 1.09% of the company’s stock.

Shares of CLX opened at $203.05 on Friday. The business’s fifty day simple moving average is $211.07 and its two-hundred day simple moving average is $214.95. The company has a current ratio of 1.41, a quick ratio of 1.06 and a debt-to-equity ratio of 2.12. Clorox Co has a 12 month low of $144.31 and a 12 month high of $239.87. The company has a market cap of $25.59 billion, a price-to-earnings ratio of 22.61, a P/E/G ratio of 4.40 and a beta of 0.26.

Clorox (NYSE:CLX) last released its quarterly earnings results on Saturday, November 7th. The company reported $3.22 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.32 by $0.90. The firm had revenue of $1.92 billion for the quarter, compared to the consensus estimate of $1.74 billion. Clorox had a return on equity of 132.72% and a net margin of 16.14%. The company’s revenue for the quarter was up 27.2% on a year-over-year basis. During the same period last year, the business posted $1.59 EPS. As a group, research analysts forecast that Clorox Co will post 8.03 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Friday, February 12th. Stockholders of record on Wednesday, January 27th will be paid a $1.11 dividend. The ex-dividend date is Tuesday, January 26th. This represents a $4.44 dividend on an annualized basis and a dividend yield of 2.19%. Clorox’s dividend payout ratio (DPR) is currently 60.33%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Scentiva, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; professional cleaning, disinfecting, and food service products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brands; professional food service products under the Hidden Valley brand; and vitamins, minerals, and supplement products under the RenewLife, Rainbow Light, Natural Vitality, NeoCell, and Stop Aging Now brands.

Further Reading: What is a support level?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.